Revvity, Inc.
RVTYNYSEHealthcareDiagnostics & Research
As of Oct 16, 2026 close
- Market cap
- $17.27B
- P/E (TTM)
- 74.56
- Forward P/E
- 77.24
- Dividend yield
- 0.18%
- 52-week range
- $81.22$166.25
- Volume (live)
- -
- Avg. volume (3M)
- 2.07M
Revvity (RVTY) Stock Price & Financial Analysis
Revvity Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $151.61 - $155.50 |
|---|---|
| 52-Week High | $166.25 |
| 52-Week Low | $81.22 |
| Open | $154.44 |
| Volume (last close) | 1.34M |
| Average Volume (3M) | 2.07M |
| Revenue (TTM) | 2.88B |
|---|---|
| Net Income (TTM) | 231.62M |
| Free Cash Flow (TTM) | 552.65M |
| EPS (TTM) | $2.06 |
| Profit Margin | 8.04% |
| Operating Margin | 12.24% |
| Return on Equity (ROE) | 3.20% |
| Debt to Equity | 0.36 |
| Annual Dividend | $0.28 |
|---|---|
| Dividend Yield | 0.18% |
| Payout Ratio | 13.56% |
| Next Dividend Ex-Date | Oct 23, 2026 |
| Market Cap | 17.27B |
|---|---|
| Shares Outstanding | 111.63M |
| P/E Ratio (TTM) | 74.56 |
| Forward P/E | 77.24 |
| Price to Sales (P/S) | 5.99 |
| Price to Book (P/B) | 2.39 |
| EV/EBITDA | 23.97 |
| 50-Day MA | $134.56 |
|---|---|
| 200-Day MA | $108.55 |
| 1-Year Change | +65.61% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Revvity at a Glance
As of the Oct 16, 2026 close, Revvity (RVTY) has a market capitalization of $17.27B. The stock trades at 74.6× trailing earnings, 77.2× forward earnings and 6.0× sales. Over the trailing twelve months it earned $231.62M on revenue of $2.88B (a 8.0% profit margin) and generated $552.65M of free cash flow. Revenue grew 0.9% year over year.
As of its latest reported balance sheet, it holds $1.02B in cash and securities against $2.63B of debt, a net debt position of $1.61B.
Revvity pays a quarterly dividend totaling $0.28 per share a year, a 0.18% yield at the Oct 16, 2026 close, with a 14% payout ratio.
The share price is up 65.6% over the past year. At $152.64 (the Oct 16, 2026 close) it sits within its 52-week range of $81.22 to $166.25, above its 200-day moving average of $108.55.
Based on 16 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $138.00, 9.6% below the Oct 16, 2026 close.
Frequently Asked Questions About Revvity
What is the current stock price for RVTY?
As of the Oct 16, 2026 close, RVTY stock trades at $152.64. The 52-week range is $81.22–$166.25, with a day range of $151.61–$155.50.
What is the P/E ratio for RVTY?
As of the Oct 16, 2026 close, Revvity's trailing twelve-month (TTM) P/E ratio is 74.6, meaning investors pay $74.6 for every $1 of annual earnings. The forward P/E is 77.2, reflecting analyst expectations for future earnings. Revvity operates in the Healthcare sector.
Does RVTY pay dividends?
Yes, Revvity pays a 0.18% annual dividend yield as of the Oct 16, 2026 close ($0.28 per share a year). The trailing twelve-month payout ratio is 13.6%. The next ex-dividend date is October 23, 2026.
What do analysts recommend for RVTY?
Based on ratings from 16 professional analysts over the last 90 days, the consensus for RVTY is Hold. The average 12-month price target is $138.00, a 9.6% downside from the Oct 16, 2026 close of $152.64.
What is the market cap of RVTY?
As of the Oct 16, 2026 close, Revvity's market capitalization is $17.04B, classifying it as a large-cap company. Revvity operates in the Healthcare sector within the Diagnostics & Research industry.